Elicio Therapeutics Inc./$ELTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Ticker
$ELTX
Sector
Primary listing
Employees
32
Headquarters
Website
ELTX Metrics
BasicAdvanced
$161M
-
-$3.88
2.15
-
Price and volume
Market cap
$161M
Beta
2.15
52-week high
$10.75
52-week low
$4.60
Average daily volume
53K
Financial strength
Current ratio
2.277
Quick ratio
2.226
Long term debt to equity
760.632
Total debt to equity
812.541
Interest coverage (TTM)
-60.34%
Profitability
EBITDA (TTM)
-44.383
Management effectiveness
Return on assets (TTM)
-123.26%
Return on equity (TTM)
-60,013.19%
Valuation
Price to book
87.26
Price to tangible book (TTM)
87.26
Price to free cash flow (TTM)
-3.941
Free cash flow yield (TTM)
-25.38%
Free cash flow per share (TTM)
-2.497
Growth
Earnings per share change (TTM)
-3.25%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Elicio Therapeutics Inc. stock?
Elicio Therapeutics Inc. (ELTX) has a market cap of $161M as of August 18, 2025.
What is the P/E ratio for Elicio Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Elicio Therapeutics Inc. (ELTX) stock is 0 as of August 18, 2025.
Does Elicio Therapeutics Inc. stock pay dividends?
No, Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next Elicio Therapeutics Inc. dividend payment date?
Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Elicio Therapeutics Inc.?
Elicio Therapeutics Inc. (ELTX) has a beta rating of 2.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.